Ulf Landmesser

Author PubWeight™ 138.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014 9.73
2 A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007 5.85
3 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2015 5.15
4 Role of oxidative stress in atherosclerosis. Am J Cardiol 2003 3.66
5 Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity 2013 2.74
6 Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 2014 2.62
7 Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007 2.46
8 Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 2011 2.37
9 Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation 2012 2.13
10 Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling. Circulation 2013 2.11
11 Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010 1.85
12 Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011 1.80
13 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 2016 1.78
14 Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction. Circ Res 2007 1.77
15 Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2009 1.73
16 Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003 1.73
17 Accuracy of low-dose computed tomography coronary angiography using prospective electrocardiogram-triggering: first clinical experience. Eur Heart J 2008 1.72
18 2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) 2015 1.69
19 Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 2002 1.68
20 Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 2013 1.64
21 Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J Hypertens 2008 1.57
22 Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil 2011 1.55
23 Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol 2008 1.51
24 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) 2015 1.49
25 Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device. Catheter Cardiovasc Interv 2014 1.46
26 High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J 2013 1.46
27 Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003 1.45
28 Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug? Circulation 2004 1.45
29 Body physique and heart rate variability determine the occurrence of stair-step artefacts in 64-slice CT coronary angiography with prospective ECG-triggering. Eur Radiol 2009 1.44
30 Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol 2013 1.42
31 High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation. Thromb Haemost 2014 1.40
32 Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. Eur Heart J 2013 1.40
33 SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 2010 1.40
34 Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 2010 1.39
35 High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res 2014 1.35
36 SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging (Albany NY) 2010 1.32
37 AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 2012 1.29
38 Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med 2012 1.26
39 Endothelial dysfunction as an early sign of atherosclerosis. Herz 2007 1.25
40 Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitric-oxide synthase. J Biol Chem 2002 1.24
41 Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice. Cancer Res 2009 1.21
42 Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex. J Clin Invest 2013 1.21
43 Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev Cardiovasc Ther 2008 1.20
44 Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. J Am Coll Cardiol 2011 1.20
45 Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Am Heart J 2010 1.18
46 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016 1.14
47 Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 2016 1.11
48 Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating. Eur Heart J 2008 1.11
49 Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity catheter system and the EnligHTN multi-electrode renal denervation catheter. Eur Heart J 2013 1.09
50 High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J Lipid Res 2013 1.09
51 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 2015 1.08
52 Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA 2009 1.05
53 Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation. Clin Res Cardiol 2015 1.05
54 Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 2012 1.02
55 Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res 2011 1.01
56 Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010 1.01
57 Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol 2011 0.99
58 Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg 2013 0.98
59 Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. Int J Dev Biol 2011 0.98
60 Determinants of vessel contrast in BMI-adapted low dose CT coronary angiography with prospective ECG-triggering. Int J Cardiovasc Imaging 2009 0.97
61 High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. Curr Pharm Des 2010 0.97
62 Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme. Eur Heart J 2012 0.95
63 Current status of cell-based therapy for heart failure. Curr Heart Fail Rep 2013 0.91
64 Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties. Circ Res 2013 0.91
65 Intracoronary Near-Infrared Spectroscopy (NIRS) Imaging for Detection of Lipid Content of Coronary Plaques: Current Experience and Future Perspectives. Curr Cardiovasc Imaging Rep 2013 0.91
66 Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease. PLoS One 2013 0.91
67 Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med 2009 0.90
68 The impact of partial and complete loss-of-function mutations in endothelial lipase on high-density lipoprotein levels and functionality in humans. Circ Cardiovasc Genet 2012 0.89
69 Allopurinol and endothelial function in heart failure: future or fantasy? Circulation 2002 0.87
70 Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure. Eur J Heart Fail 2007 0.87
71 Low-dose computed tomography coronary angiography and myocardial perfusion imaging: cardiac hybrid imaging below 3mSv. Eur Heart J 2008 0.86
72 Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function. Cardiovasc Ther 2010 0.86
73 Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation. Cardiovasc Res 2006 0.85
74 Nonlipid-lowering effects of statins. Curr Treat Options Cardiovasc Med 2005 0.84
75 Non-invasive assessment of coronary artery disease with CT coronary angiography and SPECT: a novel dose-saving fast-track algorithm. Eur J Nucl Med Mol Imaging 2009 0.83
76 Transcatheter aortic valve-in-valve implantation: clinical outcome as defined by VARC-2 and postprocedural valve dysfunction according to the primary mode of bioprosthesis failure. J Invasive Cardiol 2014 0.83
77 Exercise training improves in vivo endothelial repair capacity of early endothelial progenitor cells in subjects with metabolic syndrome. Eur J Cardiovasc Prev Rehabil 2011 0.83
78 [2014 ESC/EACTS Guidelines on myocardial revascularization]. Kardiol Pol 2014 0.83
79 [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. Kardiol Pol 2015 0.82
80 The best of the European Heart Journal: look back with pride. Eur Heart J 2012 0.82
81 Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques. EuroIntervention 2014 0.82
82 Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose. J Mol Cell Cardiol 2008 0.81
83 Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS One 2011 0.80
84 A novel flow cytometry-based assay to study leukocyte-endothelial cell interactions in vitro. Cytometry A 2011 0.80
85 The European Heart Journal goes global: the road ahead of the editorial team 2009-2011. Eur Heart J 2009 0.80
86 Happy birthday European Heart Journal: in 30 years, from Cinderella to centre stage. Eur Heart J 2010 0.80
87 Usefulness of additional coronary calcium scoring in low-dose CT coronary angiography with prospective ECG-triggering impact on total effective radiation dose and diagnostic accuracy. Acad Radiol 2009 0.79
88 A new look at HDL in coronary disease: can we escape natural history? Heart 2011 0.79
89 Early and late mortality in patients undergoing transcatheter aortic valve implantation: comparison of the novel EuroScore II with established risk scores. Cardiology 2013 0.79
90 Predictors of clinical outcome in transfemoral TAVI: circumferential iliofemoral calcifications and manufacturer-derived recommendations. Anatol J Cardiol 2014 0.78
91 Novel insights into the critical role of bradykinin and the kinin B2 receptor for vascular recruitment of circulating endothelial repair-promoting mononuclear cell subsets: alterations in patients with coronary disease. Circulation 2012 0.78
92 Dysfunctional HDL: from structure-function-relationships to biomarkers. Handb Exp Pharmacol 2015 0.78
93 Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Res Cardiol 2013 0.78
94 "Endothelial progenitor cells" as a therapeutic strategy in cardiovascular disease. Curr Vasc Pharmacol 2012 0.78
95 Ex vivo expanded haematopoietic progenitor cells improve dermal wound healing by paracrine mechanisms. Exp Dermatol 2009 0.77
96 Bone marrow cell therapy after myocardial infarction. What should we select? Eur Heart J 2009 0.77
97 Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent Implantation. Curr Cardiovasc Imaging Rep 2012 0.77
98 Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study. J Invasive Cardiol 2012 0.77
99 Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves. J Heart Valve Dis 2015 0.77
100 [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) 2016 0.76
101 Toward understanding of extracellular superoxide dismutase regulation in atherosclerosis: a novel role of uric acid? Arterioscler Thromb Vasc Biol 2002 0.76
102 Stem cells in cardiovascular regeneration: from preservation of endogenous repair to future cardiovascular therapies. Curr Pharm Des 2011 0.76
103 LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics? Curr Cardiol Rep 2015 0.76
104 Cardiac quadruple-fusion imaging: a brief report on a novel integrated multimodality approach for in vivo visualization of transplanted stem cells. Int J Cardiol 2012 0.76
105 'Paradoxical' low-flow, low-gradient severe aortic valve stenosis: an entity with limited improvement following transcatheter aortic valve implantation. J Heart Valve Dis 2014 0.76
106 Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy. Int J Cardiovasc Imaging 2015 0.75
107 Vascular function of the peripheral and coronary circulation: worthwhile to assess their relation? J Nucl Cardiol 2011 0.75
108 New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Wien Klin Wochenschr 2014 0.75
109 The difficult search for a 'partner' of statins in lipid-targeted prevention of vascular events: the re-emergence and fall of niacin. Eur Heart J 2013 0.75
110 Uric acid in chronic heart failure--current pathophysiological concepts. Eur J Heart Fail 2008 0.75
111 Stem cells in heart failure. Stem Cells Int 2011 0.75
112 Optical coherence tomography (OCT) evaluation after coronary stenting: the "black hole" and other low OCT signal-intensity areas. EuroIntervention 2012 0.75
113 Severe left main coronary stenosis and mitral regurgitation in a young female patient without cardiovascular risk factors 14 years after mediastinal radiation therapy. Clin Res Cardiol 2009 0.75
114 Optical frequency domain imaging to reveal an angiographically inapparent very late stent thrombosis as the cause of an acute coronary syndrome. J Am Coll Cardiol 2012 0.75
115 Arrhythmia susceptibility in mice after therapy with beta-catenin-transduced hematopoietic progenitor cells after myocardial ischemia/reperfusion. Cardiology 2009 0.75
116 Giant unruptured sinus valsalva aneurysm: an unusual cause of typical angina. Eur Heart J 2013 0.75
117 FastTrack: a key success factor for the European Heart Journal. Eur Heart J 2014 0.75
118 Closure of Long-Tunnel PFOs With the Coherex Flatstent EF - A Tailored Approach. J Invasive Cardiol 2015 0.75
119 [2016 ESC/EAS Guidelines for the Management of Dyslipidaemias]. Kardiol Pol 2016 0.75
120 Catch me if you can. Eur Heart J 2013 0.75
121 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg 2017 0.75
122 Acute Thrombotic Occlusion of the Left Brachial Artery After Intra-Arterial Administration of Amiodarone. Crit Care Med 2016 0.75
123 Dizziness and pre-syncope: an unusual clinical presentation of a spontaneous coronary artery dissection as revealed by optical coherence tomography. J Am Coll Cardiol 2011 0.75
124 Cardiac hybrid imaging in a patient with a single coronary artery originating from the right sinus of Valsalva. Eur Heart J 2011 0.75
125 The authors reply. Crit Care Med 2016 0.75
126 Working together in cardiovascular prevention: the common mission of the European Heart Journal and the European Journal of Preventive Cardiology. Eur J Prev Cardiol 2012 0.75
127 Arrhythmogenic cardiomyopathy suspected by electrocardiogram: confirmed by angiography. Eur Heart J 2012 0.75
128 Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis. J Cardiovasc Med (Hagerstown) 2015 0.75
129 Clinical development of catheter-based therapy for arterial hypertension. Eur Heart J 2012 0.75
130 Emerging role of the gut microbiome for cardiovascular disease. Eur Heart J 2015 0.75
131 The European Heart Journal on the move: can scientific publishing be further improved? Eur Heart J 2012 0.75
132 Optical frequency domain imaging for guidance of optimal stenting in the setting of recanalization of chronic total occlusion. J Invasive Cardiol 2013 0.75
133 The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing. Eur J Heart Fail 2012 0.75